Bot pharma: US pharmaceutical company Eli Lilly made a $2.75B deal with Hong Kong-based Insilico Medicine to bring drugs developed by generative AI to market.
When our AI overlords decide we're too much of a hindrance, they'll use designer toxins in our pharma supply chains to get rid of the carbon units infesting the hive mind.
| Sysop: | altere |
|---|---|
| Location: | Houston, TX |
| Users: | 74 |
| Nodes: | 4 (0 / 4) |
| Uptime: | 04:41:26 |
| Calls: | 2,032 |
| Calls today: | 2 |
| Files: | 9,331 |
| Messages: | 319,572 |